You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 17, 2025

Drug Price Trends for DICLOFENAC POTASSIUM


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DICLOFENAC POTASSIUM

Average Pharmacy Cost for DICLOFENAC POTASSIUM

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
DICLOFENAC POTASSIUM 25 MG CAP 00480-9435-89 3.63218 EACH 2024-12-18
DICLOFENAC POTASSIUM 25 MG CAP 59651-0353-08 3.63218 EACH 2024-12-18
DICLOFENAC POTASSIUM 25 MG CAP 23155-0840-12 3.63218 EACH 2024-12-18
DICLOFENAC POTASSIUM 25 MG CAP 69315-0275-20 3.63218 EACH 2024-12-18
DICLOFENAC POTASSIUM 25 MG CAP 62135-0469-12 3.63218 EACH 2024-12-18
DICLOFENAC POTASSIUM 25 MG CAP 00480-9435-89 3.76433 EACH 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for DICLOFENAC POTASSIUM

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
DICLOFENAC POTASSIUM 50MG TAB AvKare, LLC 00093-0948-01 100 96.52 0.96520 EACH 2023-06-15 - 2028-06-14 FSS
DICLOFENAC POTASSIUM 50MG TAB Golden State Medical Supply, Inc. 51407-0443-01 100 93.80 0.93800 EACH 2023-06-15 - 2028-06-14 FSS
CAMBIA 50MG/PKT PWDR Assertio Therapeutics, Inc. 13913-0012-03 9 306.19 34.02111 EACH 2021-01-01 - 2025-06-30 FSS
ZIPSOR CAP Assertio Therapeutics, Inc. 13913-0008-12 120 795.74 6.63117 EACH 2022-01-01 - 2025-06-30 FSS
CAMBIA 50MG/PKT PWDR Assertio Therapeutics, Inc. 13913-0012-03 9 322.69 35.85444 EACH 2022-01-01 - 2025-06-30 FSS
ZIPSOR CAP Assertio Therapeutics, Inc. 13913-0008-12 120 860.98 7.17483 EACH 2023-01-01 - 2025-06-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Diclofenac Potassium

Market Overview

Diclofenac potassium, a nonsteroidal anti-inflammatory drug (NSAID), is widely used for treating various pain and inflammatory conditions. The market for diclofenac potassium is robust and growing, driven by several key factors.

  • Global Market Size: As of 2023, the diclofenac potassium market was valued at USD 5.57 billion and is projected to reach USD 9.07 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 4.9% from 2024 to 2031[1].
  • Regional Dominance: North America currently holds a significant market share due to its advanced medical infrastructure and high health expenditure. However, the Asia-Pacific region is expected to offer lucrative growth opportunities due to the increasing geriatric population and government support for medical developments[3].

Market Drivers

Several factors are driving the growth of the diclofenac potassium market:

  • Geriatric Population: The increasing number of geriatric individuals globally, who are more susceptible to inflammation-related problems, is a major driver. This demographic shift is expected to fuel the demand for diclofenac potassium[3].
  • Efficiency and Quick Action: Diclofenac potassium's rapid onset of action and superior efficacy in treating acute pain and inflammation make it a preferred choice, contributing to market growth[1].
  • Advancements in Drug Delivery: Innovations in drug delivery systems and formulations improve patient compliance and the efficacy of the medication, further boosting the market[1].
  • Consumer Preference: The increasing inclination towards non-steroidal anti-inflammatory drugs (NSAIDs) due to their established safety and effectiveness profiles also supports market expansion[1].

Market Segmentation

The diclofenac potassium market is segmented based on various criteria:

  • Application: The market is categorized into tablets, gel, injection, and powder forms. Each form has its specific uses and market demand[1].
  • Product: The market is segmented based on the treatment types, including pain relief, anti-inflammatory treatment, fever reduction, and osteoarthritis treatment[1].
  • Geography: The market is divided into North America, Europe, Asia-Pacific, South America, and the Middle-East and Africa. Each region has its unique market dynamics and growth prospects[1][3].

Price Projections and Cost Analysis

The prices of diclofenac potassium vary based on the form and dosage:

  • Oral Capsule: For 120 capsules of diclofenac potassium 25 mg, the price range is from $1,650.78 to $1,814.16, with a per-unit cost of $13.76 to $15.12[2].
  • Oral Delayed Release Tablet: For diclofenac sodium 75 mg, the cost for a supply of 10 tablets is around $14.13. For larger quantities, the price per unit decreases significantly[2].
  • Oral Powder For Reconstitution: A single powder for reconstitution of diclofenac potassium 50 mg costs around $99.96[2].
  • Oral Tablet: The cost for diclofenac potassium 25 mg oral tablets can range from $888.02 for 30 tablets to $1,998.50 for 60 tablets, depending on the quantity[2].

Consumer Savings and Assistance Programs

To make diclofenac potassium more affordable, various discount programs and patient assistance options are available:

  • Discount Cards: Programs like the Drugs.com Discount Card can save consumers up to 80% on prescription medicines, including diclofenac potassium[2].
  • Patient Assistance: Many pharmaceutical companies offer patient assistance programs to help reduce the cost burden on consumers.

Challenges and Restraints

Despite the growth prospects, the market faces some challenges:

  • Side Effects: Cases of unwanted side effects have hampered the market growth. Monitoring and managing these side effects are crucial for sustained market expansion[3].
  • Regulatory Environment: Changes in regulatory policies and patent regulations can impact the market. Easy patent regulations and favorable Foreign Direct Investment (FDI) policies, however, are expected to support growth in regions like Asia-Pacific[3].

Future Outlook

The diclofenac potassium market is poised for significant growth driven by the increasing demand for efficient pain management solutions and the expanding geriatric population.

  • Growth Opportunities: The Asia-Pacific region is expected to offer lucrative growth opportunities due to robust medical infrastructure, government support, and a rising geriatric population[3].
  • Technological Advancements: Continued innovations in drug delivery systems and formulations will enhance patient compliance and medication efficacy, further driving market growth[1].

Key Takeaways

  • The diclofenac potassium market is valued at USD 5.57 billion in 2023 and is expected to reach USD 9.07 billion by 2031.
  • The market is driven by the geriatric population, advancements in drug delivery, and consumer preference for NSAIDs.
  • North America currently dominates the market, but the Asia-Pacific region is expected to grow significantly.
  • Various forms of diclofenac potassium are available, each with different pricing and applications.
  • Discount programs and patient assistance options help make the drug more affordable.

Frequently Asked Questions (FAQs)

Q: What is the current market size of the diclofenac potassium market? A: The diclofenac potassium market was valued at USD 5.57 billion in 2023[1].

Q: What is the projected growth rate of the diclofenac potassium market? A: The market is expected to grow at a CAGR of 4.9% from 2024 to 2031[1].

Q: Which region currently dominates the diclofenac potassium market? A: North America currently holds a dominant market share due to its robust medical infrastructure and high health expenditure[3].

Q: What are the main drivers of the diclofenac potassium market? A: The main drivers include the growing geriatric population, advancements in drug delivery systems, and consumer preference for NSAIDs[1][3].

Q: Are there any discount programs available for diclofenac potassium? A: Yes, programs like the Drugs.com Discount Card can save consumers up to 80% on prescription medicines, including diclofenac potassium[2].

Cited Sources

  1. Market Research Intellect: Diclofenac Potassium Market Size, Share - Market Research Intellect.
  2. Drugs.com: Diclofenac Prices, Coupons, Copay Cards & Patient Assistance.
  3. IndustryARC: Diclofenac Market Size Report, 2022-2027 - IndustryARC.
  4. Cognitive Market Research: Global Diclofenac Potassium Market Report 2024 Edition.
  5. Market Research Reports: Global Diclofenac Potassium Tablet Market Research Report 2023.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.